Assessing the risk of refractory disease in iTTP
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16947
Abstract: Immune thrombocytopenic purpura (iTTP) is caused by a severe acquired deficiency in the metalloprotease ADAMTS13 and is one of several disease processes manifesting as a thrombotic microangiopathy (TMA). While therapeutic plasma exchange (TPE) has proven… read more here.
Keywords: risk; refractory disease; disease; risk refractory ... See more keywords